CatalystPit

STVNStevanato Group S.p.A.

NYSE · Surgical & Medical Instruments & Apparatus
Last close $20.98 · 2026-09-30
ABOUT
ExchangeNYSE
SectorHealthcare
IndustrySurgical & Medical Instruments & Apparatus
RECENT INSIDER TRADES
  • 2026-09-30 · Stocchi Mauro (See Remarks) · SELL
  • 2026-08-10 · Magistretti Elisabetta (Director) · SELL
  • 2026-08-10 · Santel Luciano (Director) · SELL
  • 2026-08-10 · Dal Lago Marco (Chief Financial Officer) · SELL
  • 2026-06-26 · FEDERICI WILLIAM J (Director) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders138
Shares held45,834,497
Value$772.84M
Percent of shares outstanding15.13%
As of quarter end2026-06-30
RECENT NEWS
  • Ensera startet Allianz-Netzwerk mit SHL Medical, der Stevanato Group, Ypsomed, Argonaut und American Injectables
  • Ensera launches alliance network with SHL Medical, Stevanato Group, Ypsomed, Argonaut and American Injectables
  • Gastech 2026 concludes with record 59,468 attendees and US$40B in deals
  • Stevanato Group S.p.A. presents at Morgan Stanley 24th Annual Global Healthcare Conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Stevanato Group S.p.A. (STVN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit